Campbell & CO Investment Adviser LLC Nevro Corp Transaction History

Campbell & CO Investment Adviser LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.56 - $20.78 $924,547 - $1.42 Million	68,182 New	68,182 $984,000
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $344,809 - $467,571	9,465 New	9,465 $374,000
Q2 2022 Aug 09, 2022	SELL	$40.85 - $77.67 $163,032 - $309,980	-3,991 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$59.95 - $92.06 $239,260 - $367,411	3,991 New	3,991 $289,000
Q3 2021 Nov 10, 2021	SELL	$101.99 - $166.36 $178,482 - $291,130	-1,750 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$141.6 - $179.06 $247,800 - $313,355	1,750 New	1,750 $290,000
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $188,058 - $257,966	-1,416 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $195,648 - $261,025	1,416 New	1,416 $245,000
Q3 2020 Oct 15, 2020	SELL	$114.09 - $145.51 $213,804 - $272,685	-1,874 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$89.45 - $129.85 $167,629 - $243,338	1,874 New	1,874 $224,000
Q1 2020 Apr 29, 2020	SELL	$70.23 - $144.31 $194,326 - $399,305	-2,767 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$76.41 - $117.54 $211,426 - $325,233	2,767 New	2,767 $325,000

169

37.8M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $185M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.